Paper39386271
Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect model.
Lee H and 2 others. Transl Clin Pharmacol, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect model. Papers, record 39386271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39386271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Individual pharmacokinetic parameter estimation of gentamicin in an obese hemodialysis patient using non-linear mixed effect model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17050791 | Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. | J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/17050791 | PubMed |
| 2 | 21692829 | Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21692829 | PubMed |
| 3 | 28062683 | Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/28062683 | PubMed |
| 4 | 35754071 | Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35754071 | PubMed |
| 5 | 25531560 | Introduction to population pharmacokinetic/pharmacodynamic analysis with nonlinear mixed effects models. | CPT Pharmacometrics Syst Pharmacol | 2014 | https://conductscience.org/library/papers/25531560 | PubMed |
| 6 | 16332944 | Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. | Ann Pharmacother | 2006 | https://conductscience.org/library/papers/16332944 | PubMed |
| 7 | 21734439 | Rationality of administered gentamicin dose in cerebral coma patients treated in an intensive care unit. | Medicina (Kaunas) | 2011 | https://conductscience.org/library/papers/21734439 | PubMed |
| 8 | 20547809 | Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20547809 | PubMed |
| 9 | 7726530 | Aminoglycoside dosing weight correction factors for patients of various body sizes. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7726530 | PubMed |
| 10 | 3435131 | Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435131 | PubMed |
| 11 | 19832713 | Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. | Clin Microbiol Infect | 2010 | https://conductscience.org/library/papers/19832713 | PubMed |
| 12 | 16433871 | Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery. | Br J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16433871 | PubMed |
| 13 | 11564051 | The therapeutic monitoring of antimicrobial agents. | Br J Clin Pharmacol | 2001 | https://conductscience.org/library/papers/11564051 | PubMed |
| 14 | 932490 | Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys. | J Infect Dis | 1976 | https://conductscience.org/library/papers/932490 | PubMed |
| 15 | 24883145 | Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review. | J Clin Med Res | 2014 | https://conductscience.org/library/papers/24883145 | PubMed |
| 16 | 7734640 | Aminoglycoside toxicity and relation to dose regimen. | Adverse Drug React Toxicol Rev | 1994 | https://conductscience.org/library/papers/7734640 | PubMed |
| 17 | 32785707 | Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/32785707 | PubMed |
| 18 | 31016671 | A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/31016671 | PubMed |
| 19 | 4075599 | Pharmacokinetics of netilmicin in hypertonic hemodiafiltration and standard hemodialysis. | Clin Nephrol | 1985 | https://conductscience.org/library/papers/4075599 | PubMed |
| 20 | 23229487 | Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23229487 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39386271
GET https://conductscience.org/api/papers/v1/39386271/references?page=2